174 related articles for article (PubMed ID: 37249282)
1. PCSK9 promotes T helper 1 and T helper 17 cell differentiation by activating the nuclear factor-κB pathway in ankylosing spondylitis.
Cai J; Jiang Y; Chen F; Wu S; Ren H; Wang P; Wang J; Liu W
Immun Inflamm Dis; 2023 May; 11(5):e870. PubMed ID: 37249282
[TBL] [Abstract][Full Text] [Related]
2. Serum PCSK9 is positively correlated with disease activity and Th17 cells, while its short-term decline during treatment reflects desirable outcomes in ankylosing spondylitis patients.
Cai J; Jiang Y; Chen F; Wu S; Ren H; Wang P; Wang J; Liu W
Ir J Med Sci; 2023 Aug; 192(4):1785-1791. PubMed ID: 36344709
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice.
Li S; Cao H; Shen D; Chen C; Xing S; Dou F; Jia Q
J Tradit Chin Med; 2019 Aug; 39(4):524-534. PubMed ID: 32186100
[TBL] [Abstract][Full Text] [Related]
4. Xinfeng capsule improves pulmonary function in ankylosing spondylitis patients via NF-ΚB-iNOS-NO signaling pathway.
Liu J; Qi Y; Zheng L; Cao Y; Wan L; Ye W; Fang L
J Tradit Chin Med; 2014 Dec; 34(6):657-65. PubMed ID: 25618969
[TBL] [Abstract][Full Text] [Related]
5. Impact of interleukin-32α on T helper cell-related cytokines, transcription factors, and proliferation in patients with type 2 diabetes mellitus.
Borzouei S; Gholamian-Hamadan M; Behzad M
Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):268-276. PubMed ID: 36263937
[TBL] [Abstract][Full Text] [Related]
6. Threonyl-tRNA Synthetase Promotes T Helper Type 1 Cell Responses by Inducing Dendritic Cell Maturation and IL-12 Production
Jung HJ; Park SH; Cho KM; Jung KI; Cho D; Kim TS
Front Immunol; 2020; 11():571959. PubMed ID: 33178197
[TBL] [Abstract][Full Text] [Related]
7. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of proprotein convertase subtilisin/kexin type 9 attenuates 2,4,6-trinitrobenzenesulfonic acid-induced colitis via repressing toll-like receptor 4/nuclear factor-kappa B.
Lei L; Li X; Yuan YJ; Chen ZL; He JH; Wu JH; Cai XS
Kaohsiung J Med Sci; 2020 Sep; 36(9):705-711. PubMed ID: 32396274
[TBL] [Abstract][Full Text] [Related]
9. Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
Lee GE; Kim J; Lee JS; Ko J; Lee EJ; Yoon JS
Front Endocrinol (Lausanne); 2020; 11():607144. PubMed ID: 33488522
[TBL] [Abstract][Full Text] [Related]
10. Circulating PCSK9 relates to aggravated disease activity, Th17/Treg imbalance, and predicts treatment outcome of conventional synthetic DMARDs in rheumatoid arthritis patients.
Meng Y; Zheng X; Zhang Z; Geng H; Li X
Ir J Med Sci; 2023 Dec; 192(6):3187-3194. PubMed ID: 36826711
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal variation of serum PCSK9 in ulcerative colitis: association with disease activity, T helper 1/2/17 cells, and clinical response of tumor necrosis factor inhibitor.
Deng J; Jiang Y; Luan L; Fu S; Huang M; Dai Z; Liao Y; Guo S; Fu Y
Ir J Med Sci; 2024 Feb; 193(1):165-172. PubMed ID: 37420045
[TBL] [Abstract][Full Text] [Related]
12.
Su H; Zhang Z; Liu Z; Peng B; Kong C; Wang H; Zhang Z; Xu Y
J Biol Chem; 2018 Jun; 293(26):10287-10302. PubMed ID: 29739853
[TBL] [Abstract][Full Text] [Related]
13. MALT1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients.
Yuan J; Xiang L; Wang F; Zhang L; Liu G; Chang X; Zhang A; Tao Y
J Clin Lab Anal; 2022 Jul; 36(7):e24472. PubMed ID: 35622982
[TBL] [Abstract][Full Text] [Related]
14. The TLR4/NF-κB signaling pathway-mediated type 2 skewing of T helper cell in cough variant asthma was counteracted by ethanol extract of Anacyclus pyrethrum root.
Zheng J; Zhang R; Liu C; Yang H; Jin X
Immunobiology; 2023 May; 228(3):152379. PubMed ID: 36990039
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation.
Molinero LL; Cubre A; Mora-Solano C; Wang Y; Alegre ML
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18529-34. PubMed ID: 23091043
[TBL] [Abstract][Full Text] [Related]
16. JNK Pathway-Associated Phosphatase Deficiency Facilitates Atherosclerotic Progression by Inducing T-Helper 1 and 17 Polarization and Inflammation in an ERK- and NF-κB Pathway-Dependent Manner.
Chen X; Fang M; Hong J; Guo Y
J Atheroscler Thromb; 2024 May; ():. PubMed ID: 38797677
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization.
Jung MY; Kim HS; Hong HJ; Youn BS; Kim TS
J Immunol; 2012 Mar; 188(6):2592-601. PubMed ID: 22345647
[TBL] [Abstract][Full Text] [Related]
18. PCSK9 promotes the secretion of pro-inflammatory cytokines by macrophages to aggravate H/R-induced cardiomyocyte injury via activating NF-κB signalling.
Yang CL; Zeng YD; Hu ZX; Liang H
Gen Physiol Biophys; 2020 Mar; 39(2):123-134. PubMed ID: 32329440
[TBL] [Abstract][Full Text] [Related]
19. MALT1 regulates Th2 and Th17 differentiation
Wang Q; Wang Y; Liu Q; Chu Y; Mi R; Jiang F; Zhao J; Hu K; Luo R; Feng Y; Lee H; Zhou D; Mi J; Deng R
Front Immunol; 2022; 13():913830. PubMed ID: 35967391
[TBL] [Abstract][Full Text] [Related]
20. 1,25(OH)
Sun D; Luo F; Xing JC; Zhang F; Xu JZ; Zhang ZH
Cell Prolif; 2018 Oct; 51(5):e12461. PubMed ID: 29687949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
